Nu Skin Enterprises (NYSE:NUS – Get Free Report) issued an update on its fourth quarter 2024 earnings guidance on Thursday morning. The company provided EPS guidance of 0.190-0.290 for the period, compared to the consensus EPS estimate of 0.200. The company issued revenue guidance of $410.0 million-$445.0 million, compared to the consensus revenue estimate of $441.0 million. Nu Skin Enterprises also updated its FY 2024 guidance to 0.650-0.750 EPS.
Nu Skin Enterprises Trading Up 1.6 %
Shares of NUS traded up $0.10 on Friday, reaching $6.55. 991,684 shares of the company’s stock were exchanged, compared to its average volume of 751,884. The company has a current ratio of 2.12, a quick ratio of 1.33 and a debt-to-equity ratio of 0.62. The stock has a market capitalization of $325.54 million, a P/E ratio of -2.20 and a beta of 1.14. The business has a 50 day moving average price of $6.85 and a two-hundred day moving average price of $9.87. Nu Skin Enterprises has a 12 month low of $5.95 and a 12 month high of $20.75.
Nu Skin Enterprises (NYSE:NUS – Get Free Report) last issued its quarterly earnings data on Thursday, August 8th. The company reported $0.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.04. The firm had revenue of $439.10 million during the quarter, compared to analysts’ expectations of $431.87 million. Nu Skin Enterprises had a negative net margin of 8.05% and a positive return on equity of 7.80%. The business’s revenue for the quarter was down 12.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.54 earnings per share. Research analysts anticipate that Nu Skin Enterprises will post 0.78 earnings per share for the current year.
Nu Skin Enterprises Announces Dividend
Analyst Ratings Changes
A number of research analysts recently issued reports on the stock. Citigroup decreased their price objective on shares of Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating for the company in a report on Tuesday, October 22nd. DA Davidson reduced their price target on shares of Nu Skin Enterprises from $12.50 to $11.00 and set a “neutral” rating for the company in a report on Monday, August 12th. Finally, StockNews.com cut shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating in a report on Wednesday, October 23rd.
Get Our Latest Analysis on Nu Skin Enterprises
About Nu Skin Enterprises
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Recommended Stories
- Five stocks we like better than Nu Skin Enterprises
- EV Stocks and How to Profit from Them
- California Resources Stock Could Be a Huge Long-Term Winner
- Consumer Discretionary Stocks Explained
- Observability Wars: Datadog and Dynatrace Vie for Data Dominance
- Ride Out The Recession With These Dividend Kings
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.